Pharmaceutical Technology

JULY 2, 2025

Robert Barrie July 2, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Yeztugo, injected twice a year, offers more convenient dosing than daily pills. The US Food and Drug Administration (FDA) approved Yeztugo last month , bringing a more convenient PrEP option for adults and adolescents at risk of HIV exposure.

HIV Treatment and Prevention Agents 52

HIV Treatment and Prevention Agents Packaging Communication Hospitals 52

Pharmaceutical Technology

JUNE 11, 2025

Robert Barrie June 11, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Gilead said it is “committed to working with regulatory authorities to resolve the issues underlying the clinical hold” Credit: Melnikov Dmitriy via Shutterstock. Gilead is considered the leading big pharma in HIV treatments.

HIV Treatment and Prevention Agents 52

HIV Treatment and Prevention Agents Communication Hospitals Packaging 52

Pharmacy Times

JUNE 23, 2025

The presentation emphasized early intervention and personalized treatment plans in managing type 2 diabetes, shifting from "treating to failure" to "treating to target." It is not indicated for type 1 diabetes and carries a boxed warning for thyroid C-cell tumors, with unknown risk in humans.

Diabetes 32

Diabetes HIV Treatment and Prevention Agents Pharmacy Technician Compounding Pharmacies 32

Pharmacy Times

JUNE 16, 2025

SHOW MORE This abstract will be presented at the Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 19 to 20, 2025. Febrile neutropenia (FN) remains a serious and common complication of chemotherapy.

Inpatient 29

Inpatient HIV Treatment and Prevention Agents Pharmacy Technician Chemotherapy 29

Pharmacy Times

JUNE 10, 2025

The convenience of once-daily dosing and a rapid IV bolus administration may offer workflow efficiencies in hospital or surgical settings, where minimizing polypharmacy and streamlining medication administration are important goals. 2 REFERENCES 1.

Pharmacy Technician 29

Pharmacy Technician HIV Treatment and Prevention Agents Compounding Pharmacies Biosimilars 29

Pharmacy Times

JULY 3, 2025

She emphasizes that treatment options are mostly supportive, making prevention through good hygiene and vaccination essential. Pharmacy Times: What are the key challenges in managing the high burden of RSV hospitalizations in older adults, and what broader strategies are needed to address them?

HIV Treatment and Prevention Agents 32

HIV Treatment and Prevention Agents Pharmacy Technician Compounding Pharmacies Hospitals 32

Pharmacy Times

JULY 1, 2025

Tafamidis, a selective transthyretin stabilizer, significantly reduces mortality and hospitalizations in ATTR-CM patients. SHOW MORE Pharmacists can help oversee the treatment process to ensure patients with transthyretin amyloid cardiomyopathy (ATTR-CM) are adhering to tafamidis.

HIV Treatment and Prevention Agents 44

HIV Treatment and Prevention Agents Pharmacy Technician Insurance Coverage and Processing Specialty Pharmacies 44